Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Gynecology

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 22 articles: HTML format Text format

Single Articles

May 2018
1. LAMBERTINI M, Moore HCF, Leonard RCF, Loibl S, et al
   Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
   J Clin Oncol. 2018 May 2:JCO2018780858. doi: 10.1200/JCO.2018.78.0858.
   PubMed     Text format     Abstract available
   
   
   March 2018
2. COLOMBO N, Huang G, Scambia G, Chalas E, et al
   Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
   J Clin Oncol. 2018 Mar 20:JCO2017762781. doi: 10.1200/JCO.2017.76.2781.
   PubMed     Text format     Abstract available
   
   
   February 2018
3. GUPTA S, Maheshwari A, Parab P, Mahantshetty U, et al
   Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
   J Clin Oncol. 2018 Feb 12:JCO2017759985. doi: 10.1200/JCO.2017.75.9985.
   PubMed     Text format     Abstract available
   
   
   January 2018
4. CLARKE MA, Fetterman B, Cheung LC, Wentzensen N, et al
   Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.
   J Clin Oncol. 2018 Jan 22:JCO2017753442. doi: 10.1200/JCO.2017.75.3442.
   PubMed     Text format     Abstract available
   
   
   November 2017
5. FRENEL JS, Le Tourneau C, O'Neil B, Ott PA, et al
   Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.
   J Clin Oncol. 2017 Nov 2:JCO2017745471. doi: 10.1200/JCO.2017.74.5471.
   PubMed     Text format     Abstract available
   
   
   October 2017
6. BERCHUCK A, Secord AA, Moss HA, Havrilesky LJ, et al
   Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?
   J Clin Oncol. 2017 Oct 26:JCO2017745752. doi: 10.1200/JCO.2017.74.5752.
   PubMed     Text format    
   
   
   August 2017
7. PIGNATA S, Scambia G, Bologna A, Signoriello S, et al
   Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
   J Clin Oncol. 2017 Aug 21:JCO2017734293. doi: 10.1200/JCO.2017.73.4293.
   PubMed     Text format     Abstract available
   
   
   
8. CHILDERS CP, Childers KK, Maggard-Gibbons M, Macinko J, et al
   National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
   J Clin Oncol. 2017 Aug 18:JCO2017736314. doi: 10.1200/JCO.2017.73.6314.
   PubMed     Text format     Abstract available
   
   
   May 2017
9. BERCHUCK A, Havrilesky LJ, Kauff ND
   Is There a Role for Ovarian Cancer Screening in High-Risk Women?
   J Clin Oncol. 2017;35:1384-1386.
   PubMed     Text format    
   
   
   April 2017
10. KONECNY GE
    Understanding Exceptional Responses to Poly (ADP-ribose) Polymerase Inhibition in Sporadic Ovarian Cancer.
    J Clin Oncol. 2017;35:1151-1153.
    PubMed     Text format    
    
    
    
11. TAYLOR JS, Rajan SS, Zhang N, Meyer LA, et al
    End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.
    J Clin Oncol. 2017 Apr 7:JCO2016702894. doi: 10.1200/JCO.2016.70.2894.
    PubMed     Text format     Abstract available
    
    
    January 2017
12. CASTLE PE, Jeronimo J, Temin S, Shastri SS, et al
    Screening to Prevent Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.
    J Clin Oncol. 2017 Jan 30:JCO2016716563. doi: 10.1200/JCO.2016.71.6563.
    PubMed     Text format    
    
    
    
13. FOTOPOULOU C, Sehouli J, Aletti G, Harter P, et al
    Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.
    J Clin Oncol. 2017 Jan 9:JCO2016710723.
    PubMed     Text format    
    
    
    December 2016
14. COPUR MS, Gauchan D, Ramaekers R, Crockett D, et al
    Neoadjuvant Chemotherapy or Primary Debulking Surgery for Stage IIIC Ovarian Cancer.
    J Clin Oncol. 2016 Dec 28:JCO2016707125.
    PubMed     Text format    
    
    
    
15. SCHRAM AM, Iasonos A, Hyman DM
    Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian Cancer.
    J Clin Oncol. 2016;34:4312-4314.
    PubMed     Text format    
    
    
    September 2016
16. MEYER LA, Cronin AM, Sun CC, Bixel K, et al
    Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.
    J Clin Oncol. 2016 Sep 6. pii: JCO681239.
    PubMed     Text format     Abstract available
    
    
    August 2016
17. DRYDEN-PETERSON S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, et al
    HIV Infection and Survival Among Women With Cervical Cancer.
    J Clin Oncol. 2016 Aug 29. pii: JCO679613.
    PubMed     Text format     Abstract available
    
    
    
18. MILESHKIN LR, Freimund AE
    Improvement of Outcomes for Women With HIV Infection and Cervical Cancer.
    J Clin Oncol. 2016 Aug 29. pii: JCO690784.
    PubMed     Text format    
    
    
    July 2016
19. CHUANG LT, Feldman S, Nakisige C, Temin S, et al
    Management and Care of Women With Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.
    J Clin Oncol. 2016 Jul 5. pii: JCO683789.
    PubMed     Text format    
    
    
    May 2016
20. ABDERRAHMAN B, Jordan VC
    Estrogen Deprivation Therapy in Ovarian Cancer: An Opportunity.
    J Clin Oncol. 2016 May 23. pii: JCO673137.
    PubMed     Text format    
    
    
    March 2016
21. KILICKAP S, Tural D
    Does Adjuvant Hormone Therapy Improve Survival in Epithelial Ovarian Cancer?
    J Clin Oncol. 2016 Mar 21. pii: JCO653683.
    PubMed     Text format    
    
    
    
22. VOUTSADAKIS IA
    On Adjuvant Hormone Therapy in Epithelial Ovarian Cancer.
    J Clin Oncol. 2016 Mar 21. pii: JCO663245.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: